Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Yoshikazu Nakaoka »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yoshikazu Inoue < Yoshikazu Nakaoka < Yoshikazu Nakashima  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000267 (2010) Yoh Arita [Japon] ; Yasushi Sakata ; Takao Sudo ; Tetsuo Maeda ; Ken Matsuoka ; Keito Tamai ; Kaori Higuchi ; Wataru Shioyama ; Yoshikazu Nakaoka ; Yuzuru Kanakura ; Keiko Yamauchi-TakiharaThe efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman's disease.
000972 (2013) Yoshikazu Nakaoka ; Kaori Higuchi ; Yoh Arita ; Michio Otsuki ; Kaori Yamamoto ; Takahiro Hashimoto-Kataoka ; Taku Yasui ; Kuniyasu Ikeoka ; Tomohito Ohtani ; Yasushi Sakata ; Yoshihito Shima ; Atsushi Kumanogoh ; Keiko Yamauchi-Takihara ; Toshio Tanaka ; Tadamitsu Kishimoto ; Issei KomuroTocilizumab for the treatment of patients with refractory Takayasu arteritis.
000D75 (2015) Yoh Arita [Japon] ; Yoshikazu Nakaoka [Japon] ; Michio Otsuki [Japon] ; Kaori Higuchi [Japon] ; Takahiro Hashimoto-Kataoka [Japon] ; Taku Yasui [Japon] ; Takeshi Masaki [Japon] ; Tomohito Ohtani [Japon] ; Tadamitsu Kishimoto [Japon] ; Keiko Yamauchi-Takihara [Japon] ; Issei Komuro [Japon] ; Yasushi Sakata [Japon]Cytokine storm after cessation of tocilizumab in a patient with refractory Takayasu arteritis.
001843 (2018) Yoshikazu Nakaoka [Japon] ; Mitsuaki Isobe [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Shumpei Yokota [Japon] ; Akira Nomura [Japon] ; Seitaro Yoshida [Japon] ; Norihiro Nishimoto [Japon]Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
001942 (2019) Yoshikazu NakaokaResponse to: 'Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis' by Lee and Song.
001C30 (2019) Yoshikazu Nakaoka [Japon]Response to: 'Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis' by Liebling et al.
002805 (2020) Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
002B13 (2020) Takahiko Sugihara [Japon] ; Hitoshi Hasegawa ; Haruhito A. Uchida [Japon] ; Hajime Yoshifuji [Japon] ; Yoshiko Watanabe [Japon] ; Eisuke Amiya [Japon] ; Yasuhiro Maejima [Japon] ; Masanori Konishi [Japon] ; Yohko Murakawa [Japon] ; Noriyoshi Ogawa [Japon] ; Shunsuke Furuta [Japon] ; Yasuhiro Katsumata [Japon] ; Yoshinori Komagata [Japon] ; Taio Naniwa [Japon] ; Takahiro Okazaki [Japon] ; Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshikazu Nakaoka [Japon] ; Yoshihiro Arimura [Japon] ; Masayoshi Harigai [Japon] ; Mitsuaki Isobe [Japon]Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Yoshikazu Nakaoka" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Yoshikazu Nakaoka" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Yoshikazu Nakaoka
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021